Indian Journal of Private Psychiatry

Register      Login

VOLUME 19 , ISSUE 1 ( January-June, 2025 ) > List of Articles

CASE REPORT

Cardiac Considerations in Treatment of Schizophrenia: A Case Report Highlighting the Use of Long-acting Injection Paliperidone Palmitate Depot in Schizophrenia Patient with Comorbid Wolff-Parkinson-White Syndrome

Suparna Kumar, Sangha Mitra Godi

Keywords : Case report, Electrocardiogram changes, Paliperidone depot, Schizophrenia, Wolff-Parkinson-White syndrome

Citation Information : Kumar S, Godi SM. Cardiac Considerations in Treatment of Schizophrenia: A Case Report Highlighting the Use of Long-acting Injection Paliperidone Palmitate Depot in Schizophrenia Patient with Comorbid Wolff-Parkinson-White Syndrome. Ind J Priv Psychiatry 2025; 19 (1):48-50.

DOI: 10.5005/jp-journals-10067-0187

License: CC BY-NC 4.0

Published Online: 19-02-2025

Copyright Statement:  Copyright © 2025; The Author(s).


Abstract

The effect of antipsychotics on electron-conduction abnormalities in already diagnosed Wolff-Parkinson-White (WPW) syndrome is under-evaluated which creates a dilemma among practitioners in choosing an effective antipsychotic with minimal side effects. Paliperidone, a second-generation antipsychotic, is Food and Drug Administration (FDA) approved for treating schizophrenia, but the studies have documented mixed results on its effect on QT prolongation. Hence, we are going to present a case of paranoid schizophrenia with comorbid WPW syndrome showing a remarkable response on long-acting paliperidone palmitate depot with no effect on QT prolongation, even after a 2-month follow-up of electrocardiogram (ECG) report.


PDF Share
  1. Chhabra L, Goyal A, Benham MD. Wolff-Parkinson-White Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554437/.
  2. Galletly CA. Premature death in schizophrenia: Bridging the gap. Lancet Psychiatry 2017;4(4):263–265. DOI: 10.1016/S2215-0366(17)30079-2.
  3. Suba S, Dzikowicz DJ, Kozik TM, et al. Narrow vs wide QRS complex tachycardia in a patient with Wolf-Parkinson-White syndrome. Am J Crit Care Off Publ Am Assoc Crit-Care Nurses 2022;31(3):255–256. DOI: 10.4037/ajcc2022819.
  4. Enomoto S, Yoshino A, Takase B, et al. Electroconvulsive therapy-induced Wolff-Parkinson-White syndrome: A case report. Gen Hosp Psychiatry 2013;35(5):575.e7–575.e8. DOI: 10.1016/j.genhosppsych.2013.02.004.
  5. He L, Yu Y, Wei Y, et al. Characteristics and spectrum of cardiotoxicity induced by various antipsychotics: A real-world study from 2015 to 2020 based on FAERS. Front Pharmacol 2021;12:815151. DOI: 10.1016/j.genhosppsych.2013.02.004.
  6. Su KP, Lane HY, Chuang CL, et al. Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome. Schizophr Res 2004;66(2–3):191–192. DOI: 10.1016/S0920-9964(03)00182-8.
  7. Imran TF, Niazi OT, Amin R, et al. Risperidone unmasking an accessory pathway. Int J Cardiol 2015;187:488–490. DOI: 10.1016/j.ijcard.2015.03.419.
  8. Chen M, Gomaa H, Cortez-Resendiz A, et al. Quetiapine and Wolf-Parkinson-White syndrome. Case Rep Psychiatry 2020;2020:e6633385. DOI: 10.1155/2020/6633385.
  9. Kochen SA, Hakkers CS, van Gorp F, et al. Olanzapine postinjection delirium/sedation syndrome after long-acting olanzapine depot injection presenting to the emergency department: Practical guidelines for diagnosis and management. Emerg Med J EMJ 2024. DOI: 10.1136/emermed-2024-213972.
  10. Citrome L. Paliperidone palmitate - Review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication. Int J Clin Pract 2010;64(2):216–239. DOI: 10.1111/j.1742-1241.2009.02240.x.
  11. Lee HJ, Choi JS, Choi BH, et al. Inhibition of cloned hERG potassium channels by risperidone and paliperidone. Naunyn Schmiedebergs Arch Pharmacol 2017;390(6):633–642. DOI: 10.1007/s00210-017- 1364-5.
  12. Suzuki Y, Fukui N, Watanabe J, et al. QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone. Hum Psychopharmacol 2012;27(1):39–42. DOI: 10.1002/hup.1258.
  13. Spina E, Crupi R. Safety and efficacy of paliperidone extended-release in acute and maintenance treatment of schizophrenia. J Cent Nerv Syst Dis 2011;3:27–41. DOI: 10.4137/JCNSD.S1607.
  14. Hough DW, Natarajan J, Vandebosch A, et al. Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: A randomized, double-blind, placebo-controlled study. Int Clin Psychopharmacol 2011;26(1):25–34. DOI: 10.1097/YIC.0b013e3283400d58.
  15. Cheung B, Levy C, Shivkumar A. First-degree atrioventricular block with tachycardia from paliperidone and mirtazapine overdose. Eur J Case Rep Intern Med 2020;7(12):001879. DOI: 10.12890/2020_001879.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.